PMV Pharmaceuticals, Inc. Human Resources Contracts & Agreements
23 Contracts & Agreements
- Bonus & Incentive Agreements (5 contracts)
- Change of Control Agreements (7)
- Compensation Agreements (3)
- Consulting Agreements (3)
- Employment Agreements (5)
- Outside Director Compensation Policy., as amended on May 5, 2022 (Filed With SEC on August 9, 2022)
- Amended and Restated Change in Control and Severance Policy Participation Agreement, dated March 24, 2022, by and between the Registrant and Deepika Jalota, Pharm.D (Filed With SEC on May 10, 2022)
- PMV PHARMACEUTICALS, INC. AMENDED & RESTATED SAB CONSULTING AGREEMENT (Filed With SEC on March 1, 2022)
- Amended and Restated Change in Control and Severance Policy Participation Agreement, dated January 14, 2022, by and between the Registrant and Deepika Jalota, Pharm.D (Filed With SEC on March 1, 2022)
- Employment Offer Letter, dated February 22, 2021, by and between the Registrant and Deepika Jalota, Pharm.D (Filed With SEC on March 1, 2022)
- Outside Director Compensation Policy (Filed With SEC on September 21, 2020)
- 2020 Equity Incentive Plan and forms of agreements thereunder, to be in effect prior to the completion of this offering (Filed With SEC on September 21, 2020)
- 2013 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on September 21, 2020)
- Consulting Agreement, dated January 1, 2016, by and between the Registrant and Arnold Levine, Ph.D (Filed With SEC on September 4, 2020)
- Consulting Agreement, dated July 14, 2017, by and between the Registrant and Richard Heyman, Ph.D (Filed With SEC on September 4, 2020)
- Outside Director Compensation Policy (Filed With SEC on September 4, 2020)
- Amended and Restated Change in Control and Severance Policy Participation Agreement, dated August 18, 2020, by and between the Registrant and Deepika Jalota, Pharm.D (Filed With SEC on September 4, 2020)
- Amended and Restated Change in Control and Severance Policy Participation Agreement, dated August 18, 2020, by and between the Registrant and Leila Alland, M.D (Filed With SEC on September 4, 2020)
- Amended and Restated Change in Control and Severance Policy Participation Agreement, dated August 17, 2020, by and between the Registrant and Winston Kung (Filed With SEC on September 4, 2020)
- Amended and Restated Change in Control and Severance Policy Participation Agreement, dated August 17, 2020, by and between the Registrant and David H. Mack, Ph.D (Filed With SEC on September 4, 2020)
- Change in Control and Severance Policy (Filed With SEC on September 4, 2020)
- Employee Incentive Compensation Plan (Filed With SEC on September 4, 2020)
- Employment Offer Letter, dated August 18, 2020, by and between the Registrant and Deepika Jalota, Pharm.D (Filed With SEC on September 4, 2020)
- Employment Offer Letter, dated August 18, 2020, by and between the Registrant and Leila Alland, M.D (Filed With SEC on September 4, 2020)
- Employment Offer Letter, dated August 17, 2020, by and between the Registrant and Winston Kung (Filed With SEC on September 4, 2020)
- Employment Offer Letter, dated August 17, 2020, by and between the Registrant and David H. Mack, Ph.D (Filed With SEC on September 4, 2020)
- 2020 Equity Incentive Plan and forms of agreements thereunder, to be in effect prior to the completion of this offering (Filed With SEC on September 4, 2020)
- 2013 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on September 4, 2020)
